Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Receivables - Net: 2020

Historic Receivables - Net for Janux Therapeutics (JANX) over the last 1 years, with Dec 2020 value amounting to $8.0 million.

  • Janux Therapeutics' Receivables - Net was N/A to $7.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $7.5 million, marking a year-over-year change of. This contributed to the annual value of $8.0 million for FY2020, which is N/A change from last year.
  • Per Janux Therapeutics' latest filing, its Receivables - Net stood at $8.0 million for FY2020.
  • In the past 5 years, Janux Therapeutics' Receivables - Net ranged from a high of $8.0 million in FY2020 and a low of $8.0 million during FY2020.
  • For the 1-year period, Janux Therapeutics' Receivables - Net averaged around $8.0 million, with its median value being $8.0 million (2020).